Subscription to raise £900,000 to progress proprietary TYK2/JAK1 programmes through final stages of preclinical development
Subscription to raise £900,000 to progress proprietary TYK2/JAK1 programmes through final stages of preclinical development
Sareum Notes SRA737 Combination Data to be Presented at the AACR Annual Meeting
Midatech yesterday published a business update which included a number of elements of positive news. These included:
Expansion of Partnership with Daewoong Pharmaceutical to Include COVID-19 Neutrali s ing Affimer Therapy